plasminogen


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

plas·min·o·gen

 (plăz-mĭn′ə-jən)
n.
The inactive precursor to plasmin that is found in body fluids and blood plasma.

plasminogen

(plæzˈmɪnədʒən)
n
(Biochemistry) biochem a zymogen found in blood that gives rise to plasmin on activation

plas•min•o•gen

(plæzˈmɪn ə dʒən, -ˌdʒɛn)

n.
a substance in the blood that forms plasmin when activated.
[1940–45]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.plasminogen - an inactive form of plasmin that occurs in plasma and is converted to plasmin by organic solvents
fibrinolysin, plasmin - an enzyme that dissolves the fibrin of blood clots
Translations

plas·min·o·gen

[MIM*173350]
n. plasminógeno, sustancia que se encuentra en líquidos del organismo y en el plasma.
References in periodicals archive ?
There is interest in plasminogen due to its high levels in milk.
It has been shown in animal models that plasminogen activation occurs locally within skeletal muscle following injury and this activation plays a role in muscle regeneration (23).
However, repeated measures ANOVA showed that NONcNZO10 males maintained significantly higher plasma concentrations of two adipokines, resistin and plasminogen activator inhibitor-1, and the pro-inflammatory cytokine/adipokine macrophage chemoattractant protein-1.
AnaSpec is pleased to introduce two plasminogen activator assay kits - the SensoLyteO AFC Urokinase (uPA) Assay Kit and the SensoLyteO AMC tPA Assay Kit.
The serine protease, urokinase-type plasminogen activator (uPA) plays an important role in tissue remodeling, cell migration and wound healing (Toriseva and Kahari, 2008; Watanabe et al.
The antiplatelet therapy does put these patients at increased risk of developing symptomatic intracerebral hemorrhage when they receive tissue plasminogen activator (TPA).
Most strokes result from clots, but only about 1 in 20 patients receives the sole clot-dissolving drug approved for treating stroke, tissue plasminogen activator (tPA).
Patients treated under these conditions have improved combined mortality and disability outcomes at 1 year when treated with recombinant tissue plasminogen activator (rtPA) (number needed to treat [NNT]=18; 95% confidence interval [CI], 11-56) (strength of recommendation [SOR]: B, meta-analysis of randomized controlled trials with significant heterogeneity).
But they must get the powerful clotbuster Recombinant Plasminogen Activator within three hours of falling ill.
The enzyme, plasminogen activator inhibitor-1, is also a strong risk marker for heart disease, particularly in diabetics.

Full browser ?